US 10400045
Internalizing human monoclonal antibodies targeting prostate and other cancer cells
granted A61KA61K47/6811A61K47/6829
Quick answer
US patent 10400045 (Internalizing human monoclonal antibodies targeting prostate and other cancer cells) held by The Regents of the University of California expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K47/6811, A61K47/6829, A61K47/6849, A61K47/6869